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lation, PUD, GERD, CHF, prevention of complications
of menopause, and flu vaccine administration. 
CONCLUSIONS: These community pharmacists indi-
cated a strong obligation to provide various pharmaceu-
tical care services across all domains measured. The psy-
chosocial domain, which measured the benefit received
by the patient from this service, ranked highest, followed
by the professional domain, indicating that it was the
pharmacist’s professional responsibility to provide this
care. Next in order was the financial domain, which mea-
sured pharmacist reimbursement potential, followed by
the humanistic domain, indicating a nonprofessional (i.e.,
compassionate) reason for providing care.
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OBJECTIVE: The first study objective was to anony-
mously measure the value community pharmacist research
network members placed on the following pharmaceutical
care services: patient counseling, patient education on dis-
ease self-management, and disease screening and detec-
tion. The second objective was to assess the value these
pharmacists placed on providing pharmaceutical care to
patients with 10 specific disease states. 
METHODS: Sixty community pharmacists were mailed
a questionnaire asking them to rank on a scale of 1 to 10
(1  no value; 10  high value) their perceived “value”
of providing pharmaceutical care in the areas of patient
counseling (as defined by OBRA regulations), education
on disease self-management, and disease screening and
detection. They were also asked the perceived “value” of
providing pharmaceutical care in 10 disease areas. In order
to avoid surveyor bias, no specific definition of “value”
was given. 
RESULTS: Thirty-eight pharmacists (63.3%) completed
questionnaires. The average scores were as follows: pa-
tient counseling 7.08  1.82, self management 7.62 
1.46, and disease screening and detection 6.94  1.95.
The average score for all disease areas was 7.36  1.81,
with a range of 5.89 to 8.18. Rank order values for the 10
disease areas were as follows: diabetes 8.18  1.67,
asthma 8.00  1.59, hypertension 7.95  1.89, disorders
requiring anticoagulation 7.50  1.27, hypercholester-
olemia 7.37  1.75, peptic ulcer disease 6.74  1.90,
congestive heart failure 6.68  1.82, gastroesophageal re-
flux disease 6.68  1.88, prevention of menopause com-
plications 6.63  1.88, and flu vaccine administration
5.89  2.40. 
CONCLUSIONS: Pharmacists placed a high value on the
provision of the three evaluated pharmaceutical care ser-
vices. Additionally, pharmacists recognized significant
benefit in the provision of pharmaceutical care for spe-
cific disease states.
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OBJECTIVE: Data from a randomized cohort study are
used to evaluate whether pharmacist consultation (PC)
interventions have a favorable impact on patient survival
and hospitalization. 
METHODS: Since about 80% of the patients switched be-
tween the alternative treatment models of consultation after
initial randomization, the estimated effect of intervention
may be significantly attenuated with a traditional “intent to
treat” analysis. Similarly, time-fixed “as treated” analysis
may also produce biased results because of the use of future
information to predict immediate events. A Cox proportional
hazards model was specified that included multiple time-
dependent intervention variables and other covariates to bet-
ter predict the effect of pharmacy interventions on the event
rate. Specifically, the number of new prescriptions filled over
time at each alternative pharmacist consultation intervention
site was introduced as the intervention variable in order to
measure the extent to which the patient was exposed to each
model of pharmacist consultation at any point in time. Sepa-
rate survival analyses were performed on population sub-
groups defined according to the level of chronic medication
used during the baseline period. Sensitivity analyses were
done under the assumption of informative censoring. 
RESULTS: The KP model pharmacist consultation which
focused increased resources on high-risk patients signifi-
cantly reduced the mortality rate relative to both alternative
pharmaceutical care treatments (State and Control models).
The KP model was also found to decrease the likelihood of
an urgent/emergency hospital admission in a high-risk group
of patients relative to consultation provided only upon pa-
tient request or judgment of the pharmacist. The State
model, which mandated consultation for all new or changed
prescription, was not found to be associated with a risk re-
duction relative to the Control model, but it decreased the
likelihood of death event or a hospital admission relative to
the KP model in the low-risk subgroup. Sensitivity and sub-
set analyses consistently supported these findings. 
CONCLUSION: Focusing more resource intensive consul-
tation on high-risk patients may be a cost-effective way of
providing pharmacist consultation in the outpatient phar-
macy setting.
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Although drug-related problems are a major source of
morbidity, the literature provides little information re-
garding utilization of ambulatory care resources for
drug-related problems. 
OBJECTIVE: The purpose of this study was to examine
the nature and extent of the use of ambulatory care services
due to adverse effects of medications in the United States. 
METHODS: This study analyzed patient records ab-
stracted from the 1996 National Ambulatory Medical
Care Survey and the National Hospital Ambulatory
Medical Care Survey. Patient visits resulting in principal
diagnoses of adverse effects of medications (ICD-9-CM
E-code 930.00–947.9) were analyzed. The resource utili-
zation and demographics associated with these visits
were examined using descriptive statistics. 
RESULTS: During 1996, 0.31% of the visits to ambulatory
settings were due to adverse effects of medications, repre-
senting an estimated 2.73 million visits per year or 1.03 vis-
its per 100 persons. The majority (87.64%) were office-
based visits. Emergency and outpatient department visits
were 7.97% and 4.39%, respectively. Visit rates for drug-
related problems were highest in whites, females, patients
over 74 years old, and patients in the West. The therapeutic
agents most often responsible for these visits were antibiot-
ics (20.36%), cardiovascular drugs (10.66%), and hor-
mones and synthetic substitutes (7.68%). The most fre-
quently cited primary reasons for the visits were skin rash
(9.89%), cough (8.56%), and adverse effect of medications
(6.52%). Other than blood pressure and blood tests, few di-
agnostic or screening services were utilized for the patients.
The medications most frequently prescribed to treat these
problems were corticosteroids, antihistamines, and drugs
for GI disorders. The majority (81.54%) of the drug-related
visits included instructions for a return visit and 1.40% of
the drug-related visits resulted in hospital admission. 
CONCLUSION: Utilization patterns due to drug-related
problems can pose a significant burden on ambulatory
care resources. Pharmaceutical care can play an impor-
tant role in reducing these problems.
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Very little has been done to model the utilization of am-
bulatory care empirically. 
OBJECTIVE: The purpose of this study is to estimate the
expected frequency of outpatient visits from the sociode-
mographic characteristics, health status, and comorbidities. 
METHOD: A randomized sample of 6000 southern Cali-
fornia patients with chronic diseases in a managed care en-
vironment were surveyed longitudinally during 1992–
1995. Simultaneously, healthcare utilization data were col-
lected from electronic data files. An expected frequency
count data model was developed by Poisson regression.
The frequency of outpatient visits from baseline was used
as a lagged dependent variable in the equation. Sociodemo-
graphic variables were used as covariates. Model over-
dispersion was corrected by appropriate power transforma-
tion. Model validity was also compared with the ordinary
least square model and the general linear model. 
RESULTS: More than 75% of the sample had five or
more outpatient visits during demonstration period with
a mean of 15 visits per patient. The model showed that
age, gender, and baseline visit were significant predictors
(p  0.0001) of future outpatient visit. Patient’s chronic
disease status along with three of the eight SF-36 health
status domains measured at baseline (bodily pain, general
health, role limitation due to physical problem) were also
statistically significant (p  0.005) in explaining the vari-
ations in future outpatient visits. Asian patients were less
likely to use ambulatory care facilities than other races
and female patients experienced greater utilization than
males. Income and employment status significantly af-
fected outpatient utilization. The count data model was
superior to the other models.
CONCLUSION: This study provided a useful alternative
empirical method to model count data in ambulatory care.
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NCQA accreditation is a “Good Housekeeping Seal” for
MCOs to evaluate how well a health plan manages its
clinical and administrative systems in continuously im-
proving healthcare for its members. A key standard in
NCQA accreditation is demonstrating quality improve-
ment. This case study outlines how manufacturer-funded
outcomes research was used by an MCO for the NCQA
quality improvement standard. 
OBJECTIVE: A national MCO and its behavioral health
carve-out sought to understand current prescribing prac-
tices by its primary care physicians and psychiatrists for the
patient population receiving antidepressant prescriptions. 
METHODS: Cross-sectional retrospective analyses were
conducted using the prescription, diagnosis, and eligibility
databases of the national MCO and its behavioral health
subsidiary. The population included adults who received
at least one antidepressant prescription in mid-1995. 
RESULTS: By prescriber type, 77% of patients who re-
ceived an antidepressant prescription from a psychiatrist
also had a depression diagnosis, compared to only 32%
of patients who were prescribed an antidepressant by a
primary care physician. Overall, only 34% of patients
treated with antidepressant also received a recorded de-
pression diagnosis. 
CONCLUSIONS: Based on these findings, the MCO and
